New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 22, 2014
10:01 EDTPERY, DE, COG, WUBA, ZURVY, PCG, DCT, AMPE, VYFC, LPT, CYBX, AGCOOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 58.com (WUBA) downgraded to Underweight from Equal Weight at Morgan Stanley... AGCO (AGCO) downgraded to Underperform from Neutral at Macquarie... Ampio (AMPE) downgraded to Hold from Buy at Jefferies... Cabot Oil & Gas (COG) downgraded to Hold from Buy at Deutsche Bank... Cyberonics (CYBX) downgraded at Canaccord... DCT Industrial (DCT) downgraded to Market Perform from Outperform at BMO Capital... Deere (DE) downgraded to Underperform from Neutral at Macquarie... Liberty Property (LPT) downgraded at BMO Capital... PG&E (PCG) downgraded to Hold from Buy at Argus... Perry Ellis (PERY) downgraded at KeyBanc... Valley Financial (VYFC) downgraded to Neutral from Buy at Compass Point... Zurich Insurance (ZURVY) downgraded to Neutral from Overweight at JPMorgan.
News For WUBA;AGCO;AMPE;COG;CYBX;DCT;DE;LPT;PCG;PERY;VYFC;ZURVY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 6, 2015
10:01 EDTWUBAOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: 58.com (WUBA) upgraded to Buy from Hold at Summit Research... Altria Group (MO) upgraded to Buy from Outperform at CLSA... Ares Commercial (ACRE) upgraded to Outperform from Market Perform at FBR Capital... BAE Systems (BAESY) upgraded to Overweight from Equal Weight at Morgan Stanley... BGC Partners (BGCP) upgraded to Strong Buy from Outperform at Raymond James... Cognizant (CTSH) upgraded to Buy on valuation at CLSA... Edwards Lifesciences (EW) upgraded to Overweight from Equal Weight at Morgan Stanley... Guess (GES) upgraded to Neutral from Underweight at Piper Jaffray... MarkWest Energy (MWE) upgraded to Overweight from Equal Weight at Barclays... Palo Alto (PANW) upgraded to Outperform following checks at Cowen... The Medicines Co. (MDCO) upgraded to Buy from Neutral at Mizuho... TripAdvisor (TRIP) upgraded to Equal Weight from Underweight at Barclays... Union Pacific (UNP) upgraded to Outperform at Cowen... United Continental (UAL) upgraded to Buy from Fair Value at CRT Capital... eHealth (EHTH) upgraded on Medicare outlook, risk/reward at RBC Capital.
05:29 EDTWUBA58.com upgraded to Buy from Hold at Summit Research
Summit Research analyst Henry Guo upgraded 58.com to Buy with a $75 price target. Shares of the China-based online marketplace closed Thursday down $1.08 to $62.60. Guo believes the recent weakness in the stock creates a buying opportunity and that 58.com's recent strategic investments to Ganji and acquisitions of Anjuke and China HR "significantly strengthen" its dominance in the China online classified market.
June 30, 2015
10:01 EDTPCGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
June 29, 2015
17:06 EDTPCGPG&E initiated with a Buy at Mizuho
Subscribe for More Information
June 26, 2015
13:21 EDTWUBA58.com puts active on report branch office reportedly raided by local regulator
Subscribe for More Information
13:16 EDTWUBA58.com office reportedly raided by local regulator in China, Bloomberg says
Subscribe for More Information
June 25, 2015
09:05 EDTCYBXSorin, Cyberonics say name of combined company will be LivaNova
Sorin and Cyberonics unveiled LivaNova as the name of their combined company, effective at the close of their proposed merger. The name was chosen through a comprehensive market research process, including participation by employees of both companies worldwide, which produced several thousand proposed names. LivaNova will operate as three business units: Cardiac Surgery, Cardiac Rhythm Management and Neuromodulation, with operating headquarters in Mirandola, Clamart and Houston, respectively. The company will have a presence in over 100 countries around the world with approximately 4,500 employees. Until the closing of the transaction, both companies will continue to operate separately under their current brand names and leadership structures. As previously announced, the transaction is expected to be completed by the end of the third calendar quarter of 2015 and is subject to approval by Cyberonics' stockholders, the receipt of required regulatory clearances, and other customary closing conditions. The cross-border merger of Sorin with and into Livanova plc, the new company that was formed to acquire both Cyberonics and Sorin as part of the proposed merger, was approved by Sorin's shareholders at its extraordinary shareholders' meeting held on May 26, 2015.
June 24, 2015
18:14 EDTDEDeere emphasizes support for Trade Promotion Authority
Deere & Company reiterated its support for Trade Promotion Authority legislation passed by the U.S. Senate after earlier approval by the U.S. House of Representatives. It now moves to U.S. President Barack Obama, who is expected to sign the bill into law. "We are pleased this important trade bill has moved another step toward enactment," said Samuel R. Allen, Deere & Company chairman and CEO. "Trade Promotion Authority strengthens the ability of the U.S. to advance a robust trade agenda that will expand jobs and opportunities for American businesses, farmers, and workers. This benefits our customers, our employees, and Deere's business opportunities."
08:04 EDTDEDeere management to meet with Evercore ISI
Meetings to be held in San Francisco on June 23 and in Los Angeles on June 24 hosted by Evercore ISI.
June 23, 2015
08:54 EDTAGCO, DEAGCO sale to Deere or CNH unlikely, says BofA/Merrill
BofA/Merrill said an AGCO (AGCO) sale to Deere (DE) or CNH (CNHI) is unlikely given antitrust factors and a tie-up with Japan's Kubota would face cultural obstacles. The firm raised its price target on Neutral rated AGCO to $58 from $53 to reflect activist investor Blue Harbour's increased stake but said industry fundamentals may still get worse.
05:59 EDTDEStocks with implied volatility below IV index mean; DE KORS
Subscribe for More Information
June 22, 2015
10:00 EDTZURVY, AGCOOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:31 EDTAMPEAmpio announces additional study ersults for Optina
Ampio announced that further data analysis from the 12-week multi-center, placebo-controlled, double-masked randomized trial identified a reversal of pathological changes and a synergistic effect with other medication. As previously reported, oral treatment with Optina has been shown to be safe and confer significant improvements in visual acuity (VA) and reductions in central retinal thickness in patients with diabetic macular edema when given the optimal dose. An independent specialized ophthalmology company reviewed a representative set of images of the eye from the trial and identified positive changes in Optina treated patients compared to placebo. These changes included the reversal of complications such as cystic lesions and subretinal fluid. Additionally, analysis revealed that 69% of the patients in the Optina™ Study received a standard of care medication that manages kidney-induced high blood pressure. The drugs referred to as ACE Inhibitors or ARBs are commonly prescribed to diabetic patients. When this group received the optimal Optina™ dose, they showed a six-letter improvement compared to placebo, regardless of whether or not they previously had anti-VEGF eye injections. There was a significant 34 micron reduction in central retinal thickness over placebo. 60% of these eyes showed a restoration of at least one line of vision compared to only 27% of placebo.
06:54 EDTAGCOAGCO upgraded to Neutral from Underweight at JPMorgan
Subscribe for More Information
05:23 EDTZURVYZurich Insurance upgraded to Buy from Hold at Jefferies

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use